- £135.32m
- £130.18m
- £13.61m
Annual balance sheet for Bioventix, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | UAS | UAS | UAS | UAS | UAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 8.08 | 6.49 | 6.13 | 5.72 | 6 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.644 | 0.646 | 0.764 | 1.17 | 1.55 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 12 | 11.5 | 11.8 | 12.1 | 12.8 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.719 | 0.844 | 0.694 | 0.576 | 0.478 |
| Long Term Investments | |||||
| Total Assets | 13.3 | 12.9 | 13.1 | 13.3 | 13.7 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.729 | 1.01 | 1.25 | 1.2 | 1.73 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Liabilities | 0.779 | 1.09 | 1.3 | 1.22 | 1.73 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 12.5 | 11.8 | 11.8 | 12.1 | 12 |
| Total Liabilities & Shareholders' Equity | 13.3 | 12.9 | 13.1 | 13.3 | 13.7 |
| Total Common Shares Outstanding |